• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
COVID-19: Pregnancy

Mode of Delivery in the Setting of COVID-19

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Ferrazzi et al. (BJOG, 2020) report on the mode of delivery and immediate neonatal outcomes in women infected with COVID-19 in Lombardy, Italy

METHODS:

  • Retrospective study
  • Setting
    • 12 hospitals in northern Italy
  • Participants
    • Confirmed COVID-19 prior to or within 36 hours after delivery
    • Delivered from March 1 to March 20, 2020
    • All consecutive cases admitted to maternity ward for delivery
  • Study design
    • Data derived from clinical records
      • General maternal characteristics | Medical or obstetric co-morbidity | Course of pregnancy | Clinical signs and symptoms | Treatment of COVID 19 infection | Mode of delivery | Neonatal data and breastfeeding
  • Primary outcome
    • Mode of delivery
    • Neonatal outcome

RESULTS:

  • Total 42 women with COVID-19
    • Mean maternal age: 32.9 years (range 21 to 44 years)
  • COVID-19 diagnosis
    • Known before admission: 19 cases
    • On hospital admission: 10 cases
    • Delivery room: 27 cases
    • Within 36 hours of delivery: 5 cases (patients still admitted)
  • Maternal clinical features
    • Most common symptoms: Fever, cough and mild dyspnoea (80%)
    • Pneumonia: 45.2%
      • Oxygen support: 36.8%
      • Critical care unit: 21.1%
  • Mode of delivery
    • Vaginal: 57.1%
    • Elective cesarean: 42.9% (18 women)
      • COVID-19 indication (e.g. worsening dyspnea): 10 cases
      • Unrelated to COVID-19: 8 cases
  • Neonatal outcomes
    • Spontaneous term: 30 cases (71.4%)
    • Spontaneous preterm birth: 5 cases
    • Elective cesarean: 6 cases
    • Two women breastfed without a mask because COVID-19 infection was diagnosed in the postpartum period
      • Their newborns tested positive for COVID-19 (days 1 and 3)
    • In one case, a newborn had a positive test after a vaginal operative delivery | Mother did not breastfeed
      • Symptoms day 3 | Recovered after 1 day of mechanical ventilation

CONCLUSION:

  • Authors acknowledge that vertical transmission risk with vaginal delivery cannot be excluded
  • However, results from this study would suggest that vaginal delivery is associated with a low risk of COVID-19 transmission
  • In addition, the author conclude that

Vaginal delivery is appropriate in mild cases and caesarean section should be reserved for women with severe respiratory problems, where delivering the baby will allow improved ventilation

Learn More – Primary Sources:

Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis


Get COVID-19 Research Summaries Direct to Your Phone

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All COVID-19: Pregnancy Posts
Next >

Related ObG Topics:

Systematic Review of Pregnancy and COVID-19: Clinical Characteristics and Outcomes from 108 Pregnancies
Clinical Characteristics of Pregnant Women with COVID-19 Pneumonia
Vertical Transmission in Pregnancies with Confirmed COVID-19

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site